Correlation between CD4 counts of HIV patients and enteric protozoan in different seasons - An experience of a tertiary care hospital in Varanasi (India). Aug 20, 2008
Thus, the present study has been aimed to elucidate the associations between diarrhoea and CD4 counts and to study the effect of HAART along with management of diarrhoea in HIV positive patients. This study is the first of its kind in this area where an attempt was made to correlate seasonal variation and intestinal protozoan infestations. (BioMed Central)
Dr. Julio Montaner takes questions on AIDS Aug 16, 2008
" Dr. Julio Montaner will take your questions - on everything from his new role as president of the International AIDS Society to the latest in AIDS research to Canada's role in the fight against AIDS. Dr. Julio Montaner (Henry Lin) Related Articles Recent before Tuesday and come back Friday morning to read Dr. Montaner's replies. Dr. Montaner is president of the International AIDS Society (IAS) and a professor of Medicine at the University of British Columbia (UBC), Vancouver. Originally from... (Globe and Mail)
Forged in the flames Aug 16, 2008
A big hit-out tax accountant Erik de Haart, 50, trains for a 250-kilometre adventure challenge across Chile's Atacama Desert, to raise funds for the Sydney Children's Hospital ... Erik de Haart survived the Bali outrage with an urge to make a difference ... Next March, Erik de Haart will cross 250 kilometres of salt plains and brutal barren hills in Chile's remote Atacama Desert on foot. (Sydney Morning Herald -- Australia)
HAART as HIV Prevention Technique Aug 15, 2008
Recent studies have shown that providing HIV-positive individuals with highly active antiretroviral therapy (HAART) may slow the spread of HIV in the population. A recent study done by has recently found that providing highly active antiretroviral therapy (HAART) to HIV-positive individuals could reduce the spread of HIV by as much as 60 ... HAART reduces the viral load in blood, semen, and vaginal fluid. (Suite101.com)
Why Some Infected With HIV Remain Symptom Free Without Antiretroviral Drugs Aug 14, 2008
8, 2005) In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new. (Aug. (Science Daily)
New Insight On HIV Transmission Risk Of Men Who Have Sex With Men Aug 11, 2008
They completed a computer-administered psychosocial assessment that showed just about half of the men had a detectable amount of virus in their blood, known as an HIV viral load, and 57 percent were on highly active antiretroviral therapy (HAART), a combination of antiretroviral drugs aimed at treating HIV. Three-quarters of the men were Caucasian and more than half were college-educated. Based on data analysis, researchers determined that about half of the participants in the study met the... (Science Daily)
Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule Aug 8, 2008
"The heat-stable formulation of ritonavir may help to further expand protease inhibitor-based HAART (highly active antiretroviral therapy) in regions where the need for refrigeration of HIV medicines is a major barrier to treatment and care," said Pedro Cahn, M.D., Ph. D., president, International AIDS Society. (PR Newswire)
HIV Expert Says 1 Step Down, 2 More To Go In Quest To Cure AIDS Aug 8, 2008
In 15 HIV-positive study participants already using highly active antiretroviral therapy, or HAART, to suppress the virus, researchers added either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor ... Hundreds of thousands of the more than 1 million Americans infected with HIV are currently using HAART, a combination usually of three of 25 potent antiviral medications ... Presentation title: HIV Persistence in HAART: Re-evaluating Prospects for Eradication. (Science Daily)
Why Treatment Isn't Effective For HIV Aug 7, 2008
(July 7, 1998) When an HIV-infected patient discontinues highly active antiretroviral therapy (HAART), the virus almost invariably rebounds to substantial levels, even if virus had become undetectable by standard. (Jan. (Science Daily)
Drug Addicts Benefit from HIV Drugs, Too Aug 6, 2008
"A large number of prior reports have demonstrated that because of issues of social instability related to illicit drug addiction, HIV-infected injecting drug users may not be deriving the full benefits of HAART (HIV drugs)," Dr. Julio Montaner of the University of British Columbia and St. Paul's Hospital in Vancouver, Canada, and colleagues wrote ... They all got highly active antiretroviral therapy or HAART -- the cocktails of drugs that help control human immunodeficiency virus, although they... (MEDLINEplus)
Long-term HIV treatment may reduce risk for atherosclerosis Aug 5, 2008
Controlling for traditional atherosclerosis risk factors such as age, family history, smoking and blood pressure, the study team found that CAC scores were almost 60 percent lower in HIV-positive men who received highly active antiretroviral therapy (HAART) for more than eight years compared to HIV-negative men. HAART, a course of treatment that involves the combination of three or more antiretrovirals, has been associated with an increase in cholesterol and other factors associated with... (EurekAlert!)
Drug addicts benefit from HIV drugs, too: study Aug 4, 2008
"A large number of prior reports have demonstrated that because of issues of social instability related to illicit drug , HIV-infected injecting drug users may not be deriving the full benefits of HAART (HIV drugs)," Dr. Julio Montaner of the University of British Columbia and St. Paul's Hospital in Vancouver, Canada, and colleagues wrote ... They all got highly active antiretroviral therapy or HAART -- the cocktails of drugs that help control human immunodeficiency virus, although they do not... (Scientific American)
No Difference In Highly Active Antiretroviral Therapy Between HIV ... Aug 4, 2008
No Difference In Highly Active Antiretroviral Therapy Between HIV-infected Injection Drug Users And Non-users. " Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users Evan Wood; Robert S. Hogg; Viviane Dias Lima; Thomas Kerr; Benita Yip; Brandon D. L. Marshall; Julio S. G. Montaner JAMA(2008). 300[5]: pp. 550 -554. Written by: Peter M Crosta Copyright: Medical News Today Not to be reproduced without permission of Medical News Today Please rate this article:... (Medical News Today)
Highly active antiretroviral therapy of similar benefit for HIV-infected injection drug users Aug 4, 2008
Contrary to the belief that HIV-infected injection drug users (IDUs) receive less benefit from highly active antiretroviral therapy (HAART), new research finds little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving HAART, according to a study in the August 6 issue of JAMA, a theme issue on HIV/AIDS. ... Since the mid-1990s, substantial reductions in illness and death related to the human immunodeficiency virus (HIV) have been documented among HIV-infected... (EurekAlert!)
The Journal of Allergy and Clinical Immunology devotes special issue to AIDS Aug 1, 2008
Also, a Rostrum article by Lin Shen and Robert F. Siliciano from Johns Hopkins University argues that highly active antiretroviral therapy (HAART) must be combined with new techniques to attack the viral reservoirs that remain even after viral replication has been stopped. Other issue highlights include original research from a National Institutes of Health multi-center group that finds an increased rate of asthma in HIV-infected children who are being treated with HAART; the report of genetic... (EurekAlert! -- Business News)
Study Disproves Belief That Hepatitis C Blunts HIV Drugs Jul 29, 2008
FRIDAY, July 25 (HealthDay News) -- A new study challenges the long-held belief that the hepatitis C virus (HCV) impairs the immune system's ability to restore itself after HIV patients are treated with highly active antiretroviral therapy (HAART) ... Researchers at Wake Forest University Baptist Medical Center focused on levels of CD4 cells -- the immune cells that are attacked by HIV -- and whether CD4 cells can rebuild after HAART is used to suppress HIV infection ... "We've been observing... (MEDLINEplus)
Drugs add 13 years to life of HIV patients Jul 25, 2008
They looked at several studies of patients living in the United States, Canada and several European countries who received drug combinations known as highly active antiretroviral therapy or HAART.. Robert Hogg of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, Canada and colleagues looked at 43,000 patients in 14 different studies. (Reuters)
Researchers disprove long-standing belief about HIV treatment Jul 25, 2008
The Wake Forest Baptist study looked at whether having HCV co-infection impairs immune restoration in patients receiving highly active anti-retroviral therapy (HAART) to suppress their HIV infection ... "We've been observing that in some patients that are co-infected with hepatitis C, we were treating their HIV with HAART but didn't always get very good restoration of CD4," said Marina Nunez, M.D., lead researcher and an assistant professor of infectious diseases ... Patients were separated into... (EurekAlert!)
Since Introduction Of Highly Active Antiretroviral Therapy, HIV Death Rate Has Decreased Jul 3, 2008
A number of studies have reported the dramatic decreases in mortality among individuals infected with human immunodeficiency virus (HIV) since the widespread introduction of highly active antiretroviral therapy (HAART) in industrialized countries ... "Considering the first years following the widespread introduction of HAART, we have estimated an 88 percent reduction in excess mortality in 2000-2001 compared with pre-1996, corresponding closely to the 87 percent reduction in the standardized... (Science Daily)
Death Rates for HIV Patients Decrease Dramatically Jul 3, 2008
Study found 5-year survival rate for those on HAART now equals general population ... Dramatic declines in death rates for HIV-infected individuals following the introduction of highly active antiretroviral therapy (HAART) in industrialized nations in the mid-90s have already been documented ... "One important thing to know is that the composition of HAART regimen will keep changing for a particular patient during his/her course of therapy depending on the development of tolerance to the... (MEDLINEplus)
Study finds people with HIV living longer Jul 2, 2008
The advent of combination drug therapy in the 1990s called highly active antiretroviral therapy, or HAART, has greatly extended the lives of many HIV-infected people, particularly in developed countries. There is no cure or vaccine but the drugs, which interfere with HIV at several levels, can keep people healthy for years even if they never eradicate the virus. (Reuters)
HIV Patients Suffer More From Osteoporosis May 30, 2008
ScienceDaily (May 29, 2008) Following the introduction of HAART (Highly Active Antiretroviral Therapy), the survival and quality of life for people infected with the human immunodeficiency virus (HIV-1) have increased in the resource-rich countries ... The principal investigator of the study, Jos; Manuel Olmos, clarifies to SINC that: As soon as Highly Active Antiretroviral Therapy was introduced, which we call HAART, this infection was transformed into a chronic disease with an acceptable... (Science Daily)
Undergoing HAART May 24, 2008
HAART involves life-long adherence to a strict medical regimen ... Highly Active Antiretroviral Therapy (HAART) is a form of involving three or more in a daily regimen to treat HIV infections and AIDS. ... There is no textbook formula on the best time for an HIV+ individual to begin HAART. Generally, it is prescribed when the CD4 cell count is 200 350 per cubic millimetre of blood and administered prior to the advanced stages of the infection. (Suite101.com)
Combination Therapy for HIV/AIDS May 22, 2008
The term Highly Active Antiretroviral Therapy/Treatment (HAART) refers to the use of a combination of three or more ARV drugs in a daily regimen ... The foundation of HAART is the Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTI) group ... Atripla goes one step further by combining three drugs, thus providing a complete HAART regimen by taking a pill daily. (Suite101.com)
Cancer risk soars in HIV-infected people: study May 21, 2008
But the advent of combination drug therapy in the 1990s called highly active antiretroviral therapy, or HAART, greatly extended the lives of many HIV-infected people, particularly in developed countries. "Most significant was the finding of anal cancer being so elevated even in the HAART era," Patel said. (Scientific American)
Summary for Patients May 20, 2008
These treatments are known as HAART (highly active antiretroviral therapy). With HAART, fewer people with HIV infection develop AIDS and the infections and types of cancer related to AIDS.. (Annals of Internal Medicine)
Wii Fit Roundtable May 17, 2008
Lord Haart - Forum Member/Gamer. It is readily apparent that the Wii Fit is a physiological manifestation of the growing trend of Edutainment the idea that education and entertainment can be delivered in a single product. (PALGN)
Hodgkin Lymphoma Risk: Why Disease Affects Some, And Not Others; New Hypothesis From Twins Study Apr 6, 2008
4, 2008) A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12). "We found that lower levels of the protein interleukin-12, involved in fighting intracellular infections, increases susceptibility to young adult Hodgkin lymphoma," says Wendy Cozen, D.O., M.P.H, associate professor of preventive medicine at the Keck School of Medicine of USC. " Cozen is lead... (Science Daily)
Gene Mutations Tied To Immune Comeback During Therapy For HIV-1 Apr 3, 2008
The findings explain why some subjects immune systems fail to have a sustained immune comeback, despite suppression of HIV-1 replication by highly active antiretroviral therapy (HAART), while others immune systems roar back ... The new results suggest that we may be able to personalize the treatment of HIV as we might be able to predict, based on the presence of these gene variations, whether someone will have a better or worse immunological response when taking HAART, said lead author Sunil K.... (Science Daily)
Study Details Heart Risks from HIV Drugs Apr 3, 2008
Personalize Your Medical News. Thursday, April 03, 2008. (MedPage Today)
Galea Life Sciences' Subsidiary Awarded Presentation Slot for Clinical Policy Abstract At 15th International Symposium on HIV and Emerging Infectious Diseases Apr 1, 2008
The clinical policy abstract is titled, ``Micronutrients and High Protein Supplementation in the Treatment of Catabolic Cachexia and the Improvement in the Quality of Life in the Era of HAART,'' (Abstract #A-081-0008-00269). Presenting author, Dr. Peggy Achenbach, discusses the evidence-based utilization of micronutrient supplementation during HAART to enhance CD4 count, decrease viral load and decrease HIV/AIDS associated involuntary muscle loss ... Nutraplete was formulated to address... (Primezone Releases)
New Chemical Tool Kit Manipulates Mitochondria, Reveals Insights Into Drug Toxicity Feb 26, 2008
12, 2002) Highly Active Antiretroviral Therapy, or HAART, is the standard of care for HIV/AIDS patients and has prolonged the lives of countless persons with the disease. HAART has been associated, however. (Science Daily)
Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary Submits Clinical Policy Abstract to 17th International AIDS Conference Feb 7, 2008
Titled ``Nutritional Intervention and the Management of Oxidative Stress in the Long Term Management of HIV Infection in the Era of HAART,'' this abstract advocates for the evidence-based utilization of Nutraplete as a standard component for the treatment of involuntary HIV/AIDS-associated muscle loss. More importantly, it was designed to correct micronutrient deficiencies found in patients diagnosed with HIV infection and serve as a requisite adjunct to Highly Active Antiretroviral Therapy... (Primezone Releases)
Antidepressants Help HIV-Infected Patients Stick to Treatment Jan 8, 2008
All patients were starting a new, highly active antiretroviral therapy (HAART) ... "The take-home point of this study is that depression carries a worse prognosis for HAART in HIV patients. However, we also found that SSRIs can reverse this and improve outcomes for HIV-depressed patients," lead author Dr. Michael A. Horberg, director of HIV/AIDS for Kaiser Permanente, said in a prepared statement ... "HIV and depression often go hand in hand. If you are HIV-infected, you should be screened... (MEDLINEplus)
Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment Dec 21, 2007
The study looked at 3,359 HIV-infected patients from seven Kaiser Permanente regions nationwide and Group Health in 2000 to 2003 to measure the effects of depression -- with and without selective serotonin reuptake inhibitors (SSRI) use -- on adherence and changes in viral and immunologic control in patients starting a new highly active antiretroviral therapy (HAART) regimen. The researchers studied the patients' HAART adherence, viral loads, and changes in CD4 T-cell counts over a 12-month... (PR Newswire)
CMV Retinitis Is Causing Blindness In Young People With HIV In The Developing World Dec 10, 2007
Cytomegalovirus (CMV), a member of the herpesvirus family, was a familiar cause of blindness and death in patients with advanced AIDS in Western countries prior to the introduction of highly active antiretroviral therapy (HAART). In the era before HAART, about 1/3 of patients with AIDS in the West suffered potentially blinding CMV retinitis ... "The stark reality is that conditions favorable to the development of CMV retinitis--patients with low CD4 counts in the absence of HAART--are most... (Science Daily)
Doctors failing to diagnose HIV early in UK Africans Dec 7, 2007
The introduction of highly active antiretroviral therapy (HAART) means that if HIV is diagnosed early in other words, before symptoms show then in most cases it becomes a chronic long term condition rather than a terminal illness. However, HIV-positive individuals who are diagnosed late are approximately fourteen times more likely to die within one year of diagnosis than those diagnosed early. (EurekAlert!)
Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome Dec 6, 2007
Montreal, December 5, 2007 Researchers in Montreal and Boston have identified a potential new treatment for the HIV/HAART*-associated Lipodystrophy Syndrome ... HAART: Highly Active Anti-Retroviral Therapies. (EurekAlert!)
Vaccines Can Improve The Lives Of HIV-infected Children Nov 30, 2007
The review paper, "The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease", indicates that PCV should be considered an important complement to highly active antiretroviral therapy (HAART), which has brought marked improvements to morbidity and mortality in HIV-infected people. The study advocates for vaccination of all infants in areas with high rates of HIV infection. (Science Daily)
UK patients get newest HIV drug Nov 19, 2007
A cocktail of three drugs collectively called HAART (highly active anti-retroviral therapy) has dramatically improved the life expectancy of patients with HIV, but resistance to these drugs is a problem. Maraviroc was approved in the US in August, where it is marketed under the name of Selzentry. (BBC News -- UK)
Lifetime trauma may speed progression of HIV, early death Nov 2, 2007
The study is the first-known in the era of highly active antiretroviral therapy (HAART) for HIV to show that traumatic life events, such as physical or sexual abuse, are associated with faster mortality, both from AIDS-related and all causes ... Unlike depression, the effects of which have been more widely studied in the era of HAART, with trauma, its possible to establish a time ordering of events. (EurekAlert!)
Researchers Knock Out HIV Oct 22, 2007
14, 2005) When researchers came up with the powerful cocktail of anti-HIV drugs known as highly active antiretroviral therapy (HAART), they hoped they had found a way to finally rid the body of the virus. But. (Science Daily)
Drug Cocktail Stops Brain Damage Caused By HIV Oct 10, 2007
The participants were given a combination of several antiretroviral drugs known as Highly Active Anti-Retroviral Therapy (HAART) for one year ... But after three months of taking HAART, those high levels of protein fell to normal levels in nearly half of the patients ... "This study confirms that neurofilament light protein serves as a useful marker in monitoring brain injury in people with HIV and in evaluating the effectiveness of HAART.". (Science Daily)
AIDS Drugs Preserve Brain, Study Finds Oct 10, 2007
The AIDS drugs combinations, known as highly active antiretroviral therapy or HAART, suppress the virus but do not remove it completely from the body ... Before HAART was available, about 20 percent of people with AIDS developed dementia ... Dr. Asa Mellgren of Goteborg University in Sweden and colleagues studied 53 men and women infected with HIV. They tested their cerebrospinal fluid, then gave them HAART for one year. (MEDLINEplus)
IDSA: Obesity, Not Wasting, Now a Concern for HIV Patients Oct 7, 2007
PUTTING BREAKING MEDICALNEWS INTO PRACTICE. Coverage of HIV/AIDS Supported by an educational grant from. (MedPage Today)
MicroRNAs may be key to HIV's ability to hide, evade drugs, Jefferson scientists find Oct 1, 2007
Researchers at Jefferson Medical College in Philadelphia have shown that when an individual infected with HIV receives a powerful cocktail of antiviral agents called HAART (highly active antiretroviral therapy), the virus calls on miRNAs to help it remain quiet and practically undetectable, temporarily shutting down its ability to replicate and infect ... While HAART can drive the number of HIV particles in the blood to practically undetectable levels, the virus is not eliminated. (EurekAlert!)
Families slam bid to save Bali bombers Sep 29, 2007
" Indonesia's National Human Rights Commission chairman Idfhal Kasim expressed support for the move, saying the death penalty was "unacceptable". "A request from Amnesty International or other human rights organisations is like moral pressure on the government to change their policy about this punishment," he said. But Australians who lost loved ones in 2002 are stunned. NSW Coogee Dolphins member Eric de Haart, whose teammates Clint Thompson and Josh Iliffe died in the blasts, said he was... (The Age)
Pregnancy may slow -- not accelerate -- progression to AIDS Sep 20, 2007
Before the advent of highly active antiretroviral therapy (HAART), many women with HIV infection or AIDS were told that becoming pregnant would be unwise because there was thought to be a 25 percent risk of transmitting the virus to the child and that the effects of pregnancy on disease progression were unclear. It is now clear that the use of HAART in pregnancy can reduce the HIV transmission to the newborn to approximately 1 percent, but the effects of pregnancy on the HIV-infected woman... (EurekAlert!)
New study on HIV/AIDS Sep 18, 2007
But those studies were conducted before the initiation of highly active anti-retroviral therapy (HAART), drug cocktails that have over the past decade dramatically reduced death and complication rates among people infected with the AIDS-causing human immunodeficiency virus (HIV) ... Above 500 of these women received HAART, including 119 of the 139 women who had at least one pregnancy during the study period. (India Times, India -- Health/Science)
Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: a cross-sectional analytical study Sep 14, 2007
Health Related Quality of Life (HRQoL) is an important outcome of Highly Active Antiretroviral Treatment (HAART). We compared the HRQoL of HIV positive patients receiving HAART with those awaiting treatment in public sector facilities in the Free State province in South Africa ... A stratified random sample of 371 patients receiving or awaiting HAART were interviewed and the EuroQol-profile, EuroQol-index and Visual Analogue Scale (VAS) were compared. (BioMed Central)
British Columbia recognizes International FASD Fetal Alcohol ... Sep 11, 2007
Hospitalization rates down for young kids with HIV -- NEW YORK (Reuters Health) - The introduction and widespread use of highly active antiretroviral therapy (HAART) in the United States has led to "dramatic decreases" in hospitalizations among HIV-infected infants and children younger than 5 years old, new evidence suggests ... Fewer kids hospitalized with HIV -- The introduction and widespread use of highly active antiretroviral therapy (HAART) in the United States has led to. (SpiritIndia)
Socioeconomic Position Associated With Effectiveness Of HIV Drugs Sep 10, 2007
The study participants were being treated with highly active antiretroviral treatment (HAART), a combination of antiretroviral drugs sometimes referred to as an AIDS cocktail ... Educational attainment and response to HAART during initial therapy for HIV-1 infection, Linda G. Marc, Marcia A. Testa, Alexander M. Walker, Gregroy K. Robbins, Robert W. Shafer, Norman B. Anderson and Lisa F. Berkman. (Science Daily)
Hospitalization rates down for young kids with HIV Aug 30, 2007
The introduction and widespread use of highly active antiretroviral therapy (HAART) in the United States has led to "dramatic decreases" in hospitalizations among HIV-infected infants and children younger than 5 years old, new evidence suggests ... NEW YORK (Reuters Health) - The introduction and widespread use of highly active antiretroviral therapy (HAART) in the United States has led to "dramatic decreases" in hospitalizations among HIV-infected infants and children younger than 5 years old,... (Scientific American)
HIV's punch brings on dementia Aug 16, 2007
Perversely, although highly active anti-retroviral therapy (HAART) helps HIV-infected people live longer and with less severe dementia, the prevalence of HAD has not declined ... "HIV dementia remains a serious issue even in the HAART era so we need new strategies and treatments to deal with it," Professor Cooper said. (The Australian)
New Data Suggest Boosted Invirase(R) has Similar Efficacy to Boosted Lopinavir in HIV Patients at 24 Weeks Jul 21, 2007
Current treatment guidelines for highly active antiretroviral therapy (HAART) include a boosted protease inhibitor (PI) as an option for first-line treatment of HIV-infected patients. However, PI-based regimens can be associated with varying degrees of lipid abnormalities, potentially increasing the long-term risk of cerebrovascular and cardiovascular disease. (PR Newswire)
Twin Pregnancy Raises Risk of HIV Spread Jun 13, 2007
Before the advent of highly active antiretroviral therapy (HAART), an effective combination of anti-HIV drugs, the mother-to-child HIV transmission rate in twin pregnancies was two to three times that in singleton pregnancies, the investigators report. Since HAART began in 1997, rates have been similarly low in both groups ... The pre-HAART data indicate that, after adjustment the data for length of pregnancy, delivery method, and other factors, the results indicate that twin pregnancy remained... (MEDLINEplus)
Treatment Outcomes Of Patients With HIV And Tuberculosis Jun 4, 2007
The study also found that the use of highly active antiretroviral therapy (HAART) during TB treatment was associated with a faster Mycobacterium tuberculosis negative culture conversion, and an improved survival rate. Prior studies by others have shown HAART treatment beneficial in preventing TB in HIV-infected individuals, but reported no beneficial TB treatment outcomes ... The investigators noted that there is a need for large randomized clinical trials to establish the optimal duration for... (Science Daily)
Breaking Merck patent may drive investment away from Brazil May 11, 2007
The launch of the first PI in 1995 led to highly active antiretroviral therapy (HAART) regimes, which combine several antiretroviral drugs from different drug classes for the treatment of HIV infected patients. NNRTIs are now "a key component of HAART regimes and are often preferred by physicians for use in first-line treatment", Oversteegen explains. (Pharmaceutical Business Review)
European Union's CHMP Issues Positive Opinion on PEGINTRON(Tm) and REBETOL(R) Combination Therapy for Hepatitis C in Patients Coinfected With HIV Apr 30, 2007
Liver disease caused by chronic hepatitis C virus is now a leading cause of morbidity and mortality among HIV patients in the developed world, where deaths due to AIDS-related diseases have declined dramatically as a result of the widespread use of highly active antiretroviral therapy (HAART) for HIV. "HCV/HIV coinfection represents a complex treatment challenge and a major concern for patients, as hepatitis C in coinfected individuals appears to have a more aggressive course," said Robert J.... (PR Newswire)
HIV Infection Seems to Raise Heart Attack Risk Apr 24, 2007
Of course, most of the patients in the study were also taking the powerful cocktail of HIV-suppressing drugs collectively known as "highly active antiretroviral therapy" (HAART). On the one hand, "HAART suppresses inflammation, which can improve cardiovascular parameters," Grinspoon noted ... "But, on the other hand, treatment with HAART also leads to worsening changes in body composition and has even more adverse effects on (blood) glucose, lipids, etcetera. So, it's a mixed bag.". (Health-Finder)
* AIDS expert touts biotech as the future Mar 31, 2007
Speaking at a celebration of 10 years of Highly Active Anti-Retroviral Therapy (HAART) use in Taiwan, Ho told the audience that Taiwan has what it takes to be an "innovation-based society" but needs to focus on encouraging development and stemming brain-drain. Taiwan introduced HAART or "cocktail" treatment in 1997 after hard lobbying by then Department of Health head Chang Po-ya (i) for funding from the Executive Yuan ... David Ho, a leader in the fight against AIDS, gives a speech to mark... (Taipei Times, Taiwan -- World)
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa Mar 18, 2007
Few studies address the use of paediatric highly active antiretroviral therapy (HAART) in Africa ... We performed a retrospective cohort study to investigate preliminary outcomes of all children eligible for HAART at Sinikithemba HIV/AIDS clinic in KwaZulu-Natal, South Africa ... From August 31, 2003 until October 31, 2005, 151 children initiated HAART. The median age at HAART initiation was 5. (BioMed Central)
Newly infected spread half of HIV Mar 3, 2007
"HAART is no replacement for enhanced behavioural approaches to reduce transmission," the editorial says. "It is expensive, and relatively toxic, and many regions of the world still have not implemented therapy to many of their infected populations. However, we argue that the current focus on increasing HIV diagnoses through more widespread testing requires a parallel strategy for minimizing ongoing transmission.". (Globe and Mail)
Treating Herpes Reduces HIV Levels in Co-Infected Women Feb 22, 2007
The researchers enrolled co-infected women in the city of Bobo-Dioulasso in Burkina-Faso, who were not eligible for highly active antiretroviral therapy (HAART) according to World Health Organization recommendations for developing countries. The study was divided into a baseline, or pre-treatment phase, and a treatment phase, each 12 weeks long, during which researchers monitored levels of HIV and herpes virus. (MedPage Today)
Cryptococcosis: New Recommendations Against Major Opportunistic Infection Feb 10, 2007
(July 9, 2001) -- Highly active anti-retroviral therapy (HAART), also known as "AIDS cocktail" therapy, is saving lives and preventing infections even in the most advanced AIDS patients, according to a new study. . (Science Daily)
